Oriola Corporation’s Interim report 1 January–31 March 2022
Oriola Corporation Stock Exchange Release 28 April 2022 at 8.30 a.m. Oriola Corporation’s Interim report 1 January–31 March 2022 Q1 2022: Turnaround actions and market demand improved profit – market environment uncertain Reporting information for 2021 has been restated to reflect Oriola’s operating model change announced October 2021 and February 2022 announced framework merger agreement with Euroapotheca for combining the respective pharmacy businesses in Sweden. Restated information, which was published on 26 April 2022, contained the new segment structure. Continuing operations